Novel Drug Delivery Systems Market Is
Expected To Reach USD 202.5 Bn By 2022
The
latest market report published by Credence Research, Inc. “Global Novel Drug
Delivery Systems (NDDS) Market - Growth, Share, Opportunities, Competitive
Analysis, and Forecast, 2016 - 2022,” the Novel Drug Delivery Systems (NDDS)
market was valued at USD 165.4 Bn and is expected to reach USD 202.5 Bn by
2022, expanding at a CAGR of 2.7% from 2016 to 2022.
Browse the full report Novel Drug
Delivery Systems (NDDS) Market - Growth, Share, Opportunities, Competitive
Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/novel-drug-delivery-systems-ndds-market
Market Insights
The
novel drug delivery system (NDDS) provides a therapeutic amount of drug to the
specific site in the body to accomplish promptly and then maintain the desired
drug concentration. The drug- delivery system should deliver drug at a rate
control by the necessarily of the body over a specified term of treatment. Market
experts suggest that, There is a continuous growth in the market of drug
delivery systems and will continue to grow at an impressive rate in future
also. The novel drug delivery technologies enable to formulate the novel drug
delivery devices by incorporating the drug molecules into new delivery systems,
thus providing numerous therapeutic and commercial advantages.
It
was observed that NDDS market was segmented on the basis of route of
administration, type of carrier and geographical region. In route of administration segment,
injectable drug delivery system was observed as the largest market in 2015
followed by oral drug delivery system. Injectable drug delivery system
comprises of several benefits over other dosage forms in cases such as
unconsciousness, nausea, in emergency clinical episodes. The injectable
administration route is the most common and efficient for delivery of active
drug substances with poor bio-availability and the drugs with a narrow
therapeutic index.
On
the basis of type of carrier, liposomes and microspheres collectively attribute
the largest share in the market in terms of revenue (USD). The key factors
assisting the growth of liposomes market are such as, biologically active
materials encapsulated within liposomes are protected to varying extent from
immediate dilution or degradation which assists drug carrier systems for the
transport of drugs and other bioactive capsules to disease-affected organs
Market Competition Assessment:
The
key players involved in the novel drug delivery systems (NDDS) market are 3M
Company, Abbott Laboratories Ltd., Amgen Inc., AstraZeneca Plc, Bausch &
Lomb, Baxter International Inc., Bayer AG, Boehringer Ingelheim, Boston
Scientific, Bristolmyers Squibb, Celgene Corporation, Cephalon, Inc.,
Genentech Inc., Genzyme Corporation,
Glaxosmithkline Plc, Johnson & Johnson,
Merck & Co., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi SA,
and Teva Pharmaceutical Industries Ltd.
Browse
all reports from same category @ http://www.credenceresearch.com/industry/pharmaceuticals-market
Key Market Movements:
North
America is expected to lead the global novel drug delivery systems market due
to high disposable income, increasing research and development activities
associated with development of drug delivery systems, high adoption rate of novel
technologies and supportive reimbursement policies.
Projected
market entry of several products and technologies during 2016 to 2022 in global
novel drug delivery systems market are expected to provide an exceptional
growth to the market
Novel
drug delivery systems market is expected to intensify the market competition,
ignition of price wars, and drive emphasis towards geographical expansion and
penetration strategies to sustain in the competition
About Us:
Credence
Research is a worldwide market research and counseling firm that serves driving
organizations, governments, non legislative associations, and not-for-benefits.
We offer our customers some assistance with making enduring enhancements to
their execution and understand their most imperative objectives. Over almost a
century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales
Manager)
Address:
105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290
No comments:
Post a Comment